Concepedia

Srivatsan Raghavan

SR

Statistics

Publications

35

Citations

4.5K

H-Index

27

Active since

1996

Affiliations

Dana-Farber Cancer Institute(Current)

Broad Institute

Harvard University

Brigham and Women's Hospital

Massachusetts General Hospital

Srivatsan Raghavan is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

1996–2025

35

Publications

35

Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer

Srivatsan Raghavan, Peter Winter, Andrew W. Navia et al. · Cell · 2021 · 589 citations · Full text

, , +17

WRN helicase is a synthetic lethal target in microsatellite unstable cancers

Edmond M. Chan, Tsukasa Shibue, James M. McFarland et al. · Nature · 2019 · 472 citations · Full text

, , +11

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Lipika Goyal, Lei Shi, Leah Y. Liu et al. · Cancer Discovery · 2019 · 371 citations · Full text

, , +17

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda et al. · Cancer Discovery · 2018 · 369 citations · Full text

, , +10

Cell polarity triggered by cell-cell adhesion via E-cadherin

Ravi A. Desai, Lin Gao, Srivatsan Raghavan et al. · Journal of Cell Science · 2009 · 249 citations · Full text

, , +16

1–5 of 35